Clinical trial
The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
NCT04028479 is registered in ClinicalTrials.gov with Taproot Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
- Lead sponsor
- Taproot Health
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 5, 2021
- Completion date
- October 31, 2024
- Enrollment
- 167 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, acute myeloid leukemia, adenocarcinoma, adenocystic carcinoma, adrenal cancer, anal cancer, appendix cancer, astrocytoma, bile duct cancer, bladder cancer, bone cancer, brain stem neoplasms, brain tumor, breast cancer, cancer of colon, cancer of pancreas, cancer, advanced, carcinoid tumor, cervical cancer, cholangiocarcinoma, chondrosarcoma, chronic myeloid leukemia, cns cancer, colon cancer, colorectal cancer, esophageal cancer, esophagus cancer, fallopian tube cancer, gestational trophoblastic tumor, glioblastoma, head and neck neoplasms, hepatic cancer, kidney cancer, larynx cancer, liposarcoma, liver cancer, lung cancer, melanoma, mesothelioma, multiple endocrine neoplasia, multiple myeloma, nasopharyngeal carcinoma, neuroendocrine tumors, non hodgkin lymphoma, osteosarcoma, ovarian cancer, pancreatic cancer, parathyroid neoplasms, parotid tumor, penile cancer, pharynx cancer, pheochromocytoma, prostate cancer, pulmonary carcinoma, rectal cancer, renal cell carcinoma, salivary gland cancer, sarcoma, sarcoma, kaposi, sarcoma,soft tissue, skin cancer, small bowel cancer, small cell carcinoma, stomach cancer, synovial sarcoma, testicular cancer, testis cancer, thymus cancer, thyroid cancer, tongue cancer, unknown primary tumors, ureter cancer, uterine cancer, vaginal cancer, vulvar cancer, waldenstrom macroglobulinemia